You're reading the free version. Trader adds the live tape and alerts.
Start tracking
PTGX Sale Disclosure
Patel Dinesh V Ph D · SEC Form 4 · Filed Aug 12, 2026
Sale
Calculated transaction value
$5.09M
Patel Dinesh V Ph D President And CEO
PTGX
Transaction date
Aug 11, 2026
Public filing date
Aug 12, 2026
Filing lag
Filed 1 day later
PTGX daily price context
Close on/before transaction
$148.29
Aug 11, 2026
First close after public filing
$151.42
Aug 13, 2026
30-day return after filing
-2.14%
Through Sep 11, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 34,239 shares @ $148.52
- SEC ownership
- Direct
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0001104659-26-095111
Filing cohort
Transactions in this filing
Showing 6 of 6
Trades
6
Issuers
1
Estimated value
$17.05M
Buys / sales
0 / 2
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Protagonist Therapeutics, Inc PTGX Current | Sale | Aug 11, 2026 | $5.09M |
| Protagonist Therapeutics, Inc PTGX | Exercise | Aug 11, 2026 | $0 |
| Protagonist Therapeutics, Inc PTGX | Exercise | Aug 11, 2026 | $738.88K |
| Protagonist Therapeutics, Inc PTGX | Exercise | Aug 10, 2026 | $1.42M |
| Protagonist Therapeutics, Inc PTGX | Sale | Aug 10, 2026 | $9.81M |
| Protagonist Therapeutics, Inc PTGX | Exercise | Aug 10, 2026 | $0 |